These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 32796454

  • 1. Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study.
    Yamanaka M, Shinya T, Otomi Y, Kubo M, Arai Y, Toba H, Bando Y, Otsuka H, Harada M.
    Nucl Med Commun; 2020 Nov; 41(11):1189-1198. PubMed ID: 32796454
    [Abstract] [Full Text] [Related]

  • 2. Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: a prospective study.
    Shinya T, Otomi Y, Kubo M, Kinoshita M, Takechi K, Uyama N, Yamanaka M, Terazawa K, Toba H, Bando Y, Otsuka H, Harada M.
    Ann Nucl Med; 2019 Jun; 33(6):414-423. PubMed ID: 30911883
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
    Hua J, Li L, Liu L, Liu Q, Liu Y, Chen X.
    Nucl Med Commun; 2021 Nov 01; 42(11):1247-1253. PubMed ID: 34269750
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
    Shi YM, Niu R, Shao XL, Zhang FF, Shao XN, Wang JF, Wang XS, Liu B, Yu WJ, Wang YT.
    Nucl Med Commun; 2020 May 01; 41(5):459-468. PubMed ID: 32187163
    [Abstract] [Full Text] [Related]

  • 7. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
    Park SY, Yoon JK, Park KJ, Lee SJ.
    Cancer Imaging; 2015 Dec 22; 15():21. PubMed ID: 26694918
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD, Li J, Li X, Xie L, Qin L, Peng F, Cheng MH.
    J Gynecol Oncol; 2019 Nov 22; 30(6):e89. PubMed ID: 31576685
    [Abstract] [Full Text] [Related]

  • 9. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on 18F-FDG PET/CT in Patients With Limited-stage Small-cell Lung Cancer With Lymph Node Involvement.
    Jin F, Qu B, Fu Z, Zhang Y, Han A, Kong L, Yu J.
    Clin Lung Cancer; 2018 Jan 22; 19(1):e101-e108. PubMed ID: 28690012
    [Abstract] [Full Text] [Related]

  • 10. Comparison of prognostic values of primary tumor and nodal 18F-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease.
    Lim CH, Hyun SH, Moon SH, Cho YS, Choi JY, Lee KH.
    Eur Radiol; 2019 Oct 22; 29(10):5288-5297. PubMed ID: 30899978
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer.
    Wumener X, Zhang Y, Zang Z, Ye X, Zhao J, Zhao J, Liang Y.
    Ann Nucl Med; 2024 Nov 22; 38(11):904-912. PubMed ID: 39078558
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer.
    Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, Sato T, Watanabe K, Kawai H, Sato S, Kanazawa S.
    Clin Nucl Med; 2009 Apr 22; 34(4):216-21. PubMed ID: 19300050
    [Abstract] [Full Text] [Related]

  • 20. Prediction of occult lymph node metastasis using SUV, volumetric parameters and intratumoral heterogeneity of the primary tumor in T1-2N0M0 lung cancer patients staged by PET/CT.
    Ouyang ML, Xia HW, Xu MM, Lin J, Wang LL, Zheng XW, Tang K.
    Ann Nucl Med; 2019 Sep 22; 33(9):671-680. PubMed ID: 31190182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.